Is cannabis the game changer for Ghana's economic growth?

For decades, cannabis has occupied a controversial place in Ghanaian society, with conversations largely centred on drug abuse, addiction, criminality and public health concerns. But what if the same plant, when scientifically cultivated, responsibly regulated and commercially processed, could contribute to Ghana’s economic transformation?

What if medicinal and industrial cannabis could create jobs, attract investment, strengthen pharmaceutical manufacturing and generate export revenue? These questions deserve serious consideration as Ghana explores the economic opportunities within a regulated cannabis industry.

The real opportunity is not simply in growing cannabis, but in building an entire industry around it.

Beyond Cultivation: Unlocking the Value Chain

Ghana has taken important steps towards developing a regulated medicinal and industrial cannabis industry. The Narcotics Control Commission Act, 2020 (Act 1019), as amended by Act 1100 of 2023, and the Narcotics Control Commission (Cultivation and Management of Cannabis) Regulations, 2023 (L.I. 2475), provide the framework for licensed cultivation of cannabis containing not more than 0.3 per cent tetrahydrocannabinol (THC) on a dry-weight basis for permitted medicinal and industrial purposes. Recreational cannabis remains illegal.

The launch of Ghana’s medicinal cannabis programme in February 2026 and the subsequent issuance of cultivation licences to two companies in July 2026 marked important steps towards translating policy into commercial activity.

However, licensing is only the beginning. The bigger question is whether Ghana will merely produce raw materials for foreign industries or develop the capacity to manufacture high-value products locally.

The cannabis value chain extends far beyond farming. It includes agricultural production, laboratory testing, scientific research, extraction, pharmaceutical manufacturing, industrial processing, packaging, transportation and international trade.

Each stage offers opportunities for businesses and workers. Licensed cultivation can support agriculture, while processing facilities, laboratories and manufacturing plants can stimulate investment and create additional economic activity.

Ghana has an opportunity to learn from its traditional commodity-export model, in which the country has often struggled to capture the full value of its natural resources through local processing and manufacturing.

Why should Ghana export raw materials when it could potentially produce pharmaceutical ingredients, industrial materials and other value-added products for international markets?

Jobs, Investment and Opportunities for Ghanaian Businesses

A well-developed cannabis industry could create employment opportunities for Ghana’s youth and skilled professionals.

Agronomists, pharmacists, laboratory technicians, chemical engineers, biotechnologists and quality assurance specialists could find opportunities in cultivation, research and manufacturing. The industry could also generate demand for lawyers, accountants, logistics professionals, security personnel, marketers and information technology specialists.

At the community level, licensed cultivation and processing facilities could support rural employment and create opportunities for eligible farmers through cooperatives and contractual farming arrangements, subject to regulatory approval.

The benefits would extend to companies outside direct cultivation. Pharmaceutical manufacturers could explore approved cannabis-derived products. Agribusinesses could invest in cultivation technologies and processing.

Laboratories could provide testing services, while logistics companies could manage secure transportation and storage. Technology firms could develop systems for product tracking and regulatory compliance.

Financial institutions, insurers and professional service providers could also explore opportunities in this emerging market.

However, the industry must not become an exclusive opportunity for a handful of large investors. Ghana should create practical pathways for qualified local businesses to participate while maintaining strict standards for security, quality and regulatory compliance.

Ultimately, the success of the industry should be measured not simply by the number of licences issued, but by the sustainable jobs created, investments attracted and opportunities made available to Ghanaians.

Pharmaceutical Research and Industrial Manufacturing

One of the most promising opportunities lies in pharmaceutical research and development.

Cannabis contains compounds such as cannabidiol (CBD), which has attracted scientific interest for its therapeutic potential. Certain purified CBD medicines have demonstrated effectiveness in treating specific forms of epilepsy, although evidence for other proposed medical uses varies.

Ghanaian universities, pharmaceutical companies and research institutions could collaborate with international partners to develop expertise in cannabinoid research, extraction, formulation and product testing.

With appropriate investment and regulatory approval, Ghana could explore the manufacture of quality-assured medicinal products and other permitted cannabis-derived ingredients.

Such developments could strengthen local pharmaceutical manufacturing, create skilled employment and encourage technology transfer.

Industrial hemp also presents potential opportunities. Its fibre can be used in textiles, ropes, paper, insulation and certain construction materials. Hemp seeds can support the production of food ingredients and industrial oils, subject to applicable regulatory requirements.

These applications could provide opportunities for Ghanaian manufacturers to diversify their products, explore import substitution and develop new export markets.

However, commercial success will depend on scientific research, suitable plant varieties, processing infrastructure, production costs and credible market demand. Not every cannabis-derived product will necessarily be profitable or competitive.

Export Earnings and Economic Diversification

A competitive medicinal and industrial cannabis sector could contribute to Ghana’s efforts to diversify its export base and generate foreign exchange. Potential export products include approved pharmaceutical ingredients, processed hemp fibre and other legally permitted industrial materials.

But Ghana cannot assume that international markets will automatically be available. Exports must comply with the laws of destination countries, applicable licensing arrangements, quality requirements and international drug control obligations.

The country must therefore prioritise market research, international partnerships, product certification and investment in processing facilities. The African Continental Free Trade Area could provide a broader framework for exploring regional trade opportunities, subject to the applicable legal and regulatory requirements.

The objective should be to retain more value within Ghana by manufacturing competitive products rather than depending exclusively on the export of unprocessed materials.

If Ghana develops the necessary technical expertise, processing capacity and market access, the industry could contribute to employment, export diversification and industrial development. The scale of these benefits, however, will depend on actual commercial performance rather than projections alone. NACOC and the Responsibility to Protect Public Health

The Narcotics Control Commission (NACOC) has a critical role in ensuring that commercial opportunities do not undermine Ghana’s drug control objectives. Effective regulation requires licensing, inspections, laboratory testing, product traceability and safeguards against diversion into illicit markets. Operators must comply with the permitted THC threshold and all applicable legal requirements.

Collaboration with scientific and regulatory institutions is equally important to ensure that products meet appropriate quality standards and that medicinal claims are supported by evidence.

Strong regulation should not be viewed simply as an obstacle to investment. It is essential to building public confidence, protecting consumers and attracting responsible investors.

A poorly regulated industry could encourage illegal diversion, undermine public health and damage Ghana’s international reputation. A transparent and accountable system, by contrast, could help balance economic development with public safety. Economic opportunity and effective drug control are not opposing objectives; with the right safeguards, they can reinforce each other. The Challenges Ghana Must Overcome

Despite its promise, cannabis is not a guaranteed solution to Ghana’s economic challenges.

The industry requires substantial investment in processing equipment, laboratory infrastructure, security and quality assurance. Ghanaian producers must also compete with established international businesses and meet demanding market standards.

Access to finance, limited technical expertise and uncertainty about export markets could further constrain growth.

There is also the danger of exaggerated expectations. The commercial success of cannabis in other countries does not guarantee comparable results in Ghana. Government, investors and research institutions must therefore rely on credible market studies, sound business plans and measurable economic indicators. Ghana should track employment, investment, export receipts, tax contributions, local participation and the number of commercially viable products developed.

Most importantly, the country must avoid repeating the mistake of becoming merely a supplier of raw materials while foreign companies capture the more profitable stages of production.

Conclusion: A Game Changer or Another Missed Opportunity?

Is cannabis the game changer for Ghana’s economic growth? The more important question is whether Ghana can transform the opportunities within its medicinal and industrial cannabis value chain into tangible economic benefits.

The country has made important progress in establishing a legal framework for regulated cultivation. But legislation and licensing alone will not deliver economic transformation.

Success will depend on the ability to attract responsible investment, strengthen scientific research, develop local processing and manufacturing, create sustainable employment and produce goods that can compete internationally.